Pathway summary
Data sourcePathways
KEGG pathwaynon small cell lung cancer, HSA05223; apoptosis, HSA04210; huntingtons disease, HSA05040; amyotrophic lateral sclerosis, HSA05030; endometrial cancer, HSA05213; chronic myeloid leukemia, HSA05220; cell cycle, HSA04110; colorectal cancer, HSA05210; basal cell carcinoma, HSA05217; mapk signaling pathway, HSA04010; bladder cancer, HSA05219; prostate cancer, HSA05215; p53 signaling pathway, HSA04115; small cell lung cancer, HSA05222; pancreatic cancer, HSA05212; glioma, HSA05214; wnt signaling pathway, HSA04310; melanoma, HSA05218; thyroid cancer, HSA05216
NCI pathwaySignaling events mediated by HDAC Class III, hdac_classiii_pathway; Direct p53 effectors, p53downstreampathway; LKB1 signaling events, lkb1_pathway; Glucocorticoid receptor regulatory network, reg_gr_pathway; AP-1 transcription factor network, ap1_pathway; BARD1 signaling events, bard1pathway; Signaling mediated by p38-alpha and p38-beta, p38alphabetadownstreampathway; p75(NTR)-mediated signaling, p75ntrpathway; p53 pathway, p53regulationpathway; Hypoxic and oxygen homeostasis regulation of HIF-1-alpha, hif1apathway; Aurora A signaling, aurora_a_pathway; PLK3 signaling events, plk3_pathway; Validated targets of C-MYC transcriptional activation, myc_activpathway
WIKI pathwaymiRNA Regulation of DNA Damage Response(Homo sapiens), WP1530; Wnt Signaling Pathway and Pluripotency(Homo sapiens), WP399; PluriNetWork(Mus musculus), WP1763; ATM Signaling Pathway(Homo sapiens), WP2516; Signaling Pathways in Glioblastoma(Homo sapiens), WP2261; Oncostatin M Signaling Pathway(Homo sapiens), WP2374; Gastric cancer network 2(Homo sapiens), WP2363; G1 to S cell cycle control(Mus musculus), WP413; RB in Cancer(Homo sapiens), WP2446; Metastatic brain tumor(Homo sapiens), WP2249; DNA Damage Response(Homo sapiens), WP707; Apoptosis(Homo sapiens), WP254; Apoptosis(Mus musculus), WP1254; Integrated Cancer pathway(Homo sapiens), WP1971; G1 to S cell cycle control(Homo sapiens), WP45; MAPK signaling pathway(Mus musculus), WP493; Amyotrophic lateral sclerosis (ALS)(Homo sapiens), WP2447; miRNA regulation of DNA Damage Response(Mus musculus), WP2087; Fluoropyrimidine Activity(Homo sapiens), WP1601; MAPK Signaling Pathway(Homo sapiens), WP382; Delta-Notch Signaling Pathway(Mus musculus), WP265; DNA Damage Response (only ATM dependent)(Homo sapiens), WP710; Cell Cycle(Homo sapiens), WP179; XPodNet - protein-protein interactions in the podocyte expanded by STRING(Mus musculus), WP2309; Spinal Cord Injury(Homo sapiens), WP2431; Alzheimers Disease(Homo sapiens), WP2059; Integrated Pancreatic Cancer Pathway(Homo sapiens), WP2377; Senescence and Autophagy(Homo sapiens), WP615; AMPK Signaling(Homo sapiens), WP1403; Folate Metabolism(Homo sapiens), WP176; ErbB Signaling Pathway(Homo sapiens), WP673; Alzheimers Disease(Mus musculus), WP2075; Integrated Breast Cancer Pathway(Homo sapiens), WP1984; miRNAs involved in DNA damage response(Homo sapiens), WP1545; TP53 Network(Homo sapiens), WP1742; Spinal Cord Injury(Mus musculus), WP2432